Clinical Trial Update: Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating recombinant human adenovirus type 5 injection with a PD-1 monoclonal antibody and nab-paclitaxel for liver metastases from malignant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases
• Malignant Melanoma

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• PD-1 monoclonal antibody
• Recombinant human adenovirus type 5 injection (not specified)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Malignant Melanoma, Liver Metastases | Phase 2 | Status: UNKNOWN